Home > NVS-BET-1

molecules of the month

<< Back to January

NVS-BET-1

Recent Publication

BRD4 (BD1/2) BET bromodomain inhibitor

wound-heal. at 1 mpk QD, bell-shaped pharm.

from phenotypic screen (MDM2 inhibitor hit)

Nat. Chem. Biol., Jan. 18, 2021

Novartis (NIBR), Basel, CH

The Novartis BET bromodomain inhibitor, NVS-BET-1, is a new chemotype of BRD4 (BD1 and BD2) inhibitor. While we recently highlighted a few high-profile, selective bromodomain inhibitors from AbbVie and…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

NVS-BET-1

this content is exclusive to Premium members

this content is exclusive to
Premium members